SKWG Stock Overview
Humanatare Distribution Corp finances and distributes life-saving healthcare products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Skywealth Group Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.28 |
| 52 Week High | US$2.54 |
| 52 Week Low | US$1.00 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -83.98% |
| 5 Year Change | 58.02% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| SKWG | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 2.0% | 1.2% |
| 1Y | n/a | 3.4% | 24.9% |
Return vs Industry: Insufficient data to determine how SKWG performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how SKWG performed against the US Market.
Price Volatility
| SKWG volatility | |
|---|---|
| SKWG Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SKWG's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine SKWG's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | n/a | Edward Andercheck | n/a |
Humanatare Distribution Corp finances and distributes life-saving healthcare products. It offers products to eradicate various diseases, such as Tuberculosis in the developing world. Humanatare Distribution Corp was formerly known as TIE Technologies, Inc. and changed its name to Humanatare Distribution Corp in July 2012.
Skywealth Group Inc. Fundamentals Summary
| SKWG fundamental statistics | |
|---|---|
| Market cap | US$288.00k |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs SKWG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SKWG income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SKWG perform over the long term?
See historical performance and comparison